BCVA Best Corrected Visual Acuity, BMI Body Mass Index, Cog Cognition, H Headache, ICP Intracranial Pressure IIH Idiopathic Intracranial Hypertension, M/S Medication use or Surgical escalation, mo month(s) OCT Optical Coherence Tomography, OR Odds Ratio, RCT Randomized Controlled Trial, RR Risk Ratio, V Visual function/Papilledema, W Weight/Body Mass Index, wk week(s) The studied GLP-1 RAs included exenatide [14, 35, 37, 39], liraglutide [27, 3639], semaglutide [27, 34, 3739], lixisenatide [37, 39], dulaglutide [37, 39], albiglutide [39] and the dual agonist (GLP-1 and Glucose-dependent insulinotropic polypeptide (GIP)) tirzepatide [29, 37]
This is why many patients who have lost 30, 40, or 50+ pounds find they are left with: A persistent lower abdominal pouch. Softness at the flanks (love handles) that masks their new waistline
Bezin J, Gouverneur A, Pnichon M, et al
Adems de su indicacin oficial, tambin se ha prescrito para el tratamiento contra la obesidad o el sobrepeso de forma off-label, es decir, fuera de su indicacin autorizada
You must make a conscious effort to drink at least 8 to 10 glasses of water a day
Such an accomplishment
